Valeant Chief Is Hospitalized With Pneumonia
Saturday, December 26, 2015 - 01:41
in Mathematics & Economics
J. Michael Pearson has been struggling to reassure investors as Valeant faces concerns about its pricing and distribution policies for its drugs.